发明名称 |
Treatment of Obesity or Diabetes with Bile Acid Sequestrants |
摘要 |
Provided herein are methods of treating obesity and diabetes with labile bile acid sequestrants. An effective amount of a labile bile acid sequestrant may be orally administered to an obese or diabetic individual. A labile bile acid sequestrant provided herein may have a low affinity in the colon or rectum of a human for at least one bile acid or bile acid mimic that stimulates L-cells. A labile bile acid sequestrant may be a non-systemic labile bile acid sequestrant.
|
申请公布号 |
US2011152204(A1) |
申请公布日期 |
2011.06.23 |
申请号 |
US20100969388 |
申请日期 |
2010.12.15 |
申请人 |
SATIOGEN PHARMACEUTICALS, INC. |
发明人 |
GEDULIN BRONISLAVA;GREENE, JR. HOWARD E. |
分类号 |
A61K31/56;A61K31/09;A61K31/131;A61K31/132;A61K31/14;A61K31/155;A61K31/20;A61P3/04;A61P3/10 |
主分类号 |
A61K31/56 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|